{"transactions":[{"id":929841,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-27T22:04:08.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":600600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests 25% on January 26, 2027, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":600600,"derivative":{"exercise_price":3.6,"expiration_date":"2036-01-26","underlying":"Common Stock","underlying_shares":600600},"source":{"system":"sec-edgar","filing":"0001193125-26-024826","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526024826/ownership.xml","form_type":"4"}},{"id":929840,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-27T22:04:08.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":100100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":368276,"source":{"system":"sec-edgar","filing":"0001193125-26-024826","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119312526024826/ownership.xml","form_type":"4"}},{"id":1295383,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-24T21:15:42.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":546000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests 25% on January 22, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":546000,"derivative":{"exercise_price":3.46,"expiration_date":"2035-01-22","underlying":"Common Stock","underlying_shares":546000},"source":{"system":"sec-edgar","filing":"0001062993-25-001078","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299325001078/form4.xml","form_type":"4"}},{"id":1295382,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-24T21:15:42.000Z","date":"2025-01-22","kind":"grant","planned":false,"acquired":true,"shares":91000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":387208,"source":{"system":"sec-edgar","filing":"0001062993-25-001078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299325001078/form4.xml","form_type":"4"}},{"id":1675010,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-19T21:31:11.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":396750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on January 17, 2025, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":396750,"derivative":{"exercise_price":4.21,"expiration_date":"2034-01-17","underlying":"Common Stock","underlying_shares":396750},"source":{"system":"sec-edgar","filing":"0001062993-24-001083","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299324001083/form4.xml","form_type":"4"}},{"id":1675009,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-19T21:31:11.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":66125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":332954,"source":{"system":"sec-edgar","filing":"0001062993-24-001083","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299324001083/form4.xml","form_type":"4"}},{"id":1886568,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-05-18T18:13:12.000Z","date":"2023-05-17","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":3.705,"value":18525.0,"ownership":{"direct":true},"balance_after":266829,"source":{"system":"sec-edgar","filing":"0001062993-23-011546","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299323011546/form4.xml","form_type":"4"}},{"id":2035355,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-03T01:15:26.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":325000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests 25% on January 31, 2024, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":325000,"derivative":{"exercise_price":4.94,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":325000},"source":{"system":"sec-edgar","filing":"0000899243-23-003734","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924323003734/doc4.xml","form_type":"4"}},{"id":2035354,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-03T01:15:26.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":205000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share is represented by a restricted stock unit (\"RSU\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement."}],"balance_after":261829,"source":{"system":"sec-edgar","filing":"0000899243-23-003734","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924323003734/doc4.xml","form_type":"4"}},{"id":2155350,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-09-19T11:00:11.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":31746,"price":3.15,"value":99999.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on September 16, 2022."}],"balance_after":56829,"source":{"system":"sec-edgar","filing":"0001062993-22-019645","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299322019645/form4.xml","form_type":"4"}},{"id":2273186,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-13T00:28:44.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on May 10, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting dates."}],"balance_after":40000,"derivative":{"exercise_price":2.92,"expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001062993-22-012309","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299322012309/form4.xml","form_type":"4"}},{"id":2429950,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-21T00:16:23.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":182000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on January 18, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":182000,"derivative":{"exercise_price":8.75,"expiration_date":"2032-01-18","underlying":"Common Stock","underlying_shares":182000},"source":{"system":"sec-edgar","filing":"0001062993-22-001319","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000106299322001319/form4.xml","form_type":"4"}},{"id":2627670,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-07-22T17:04:23.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of the Issuer's common stock"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each non-employee director of the Issuer is entitled to receive an annual grant of restricted stock units (\"RSUs\") with a value of $75,000 on the date of grant, such grants to be effective as of the date of the 2021 annual meeting of stockholders, and annually thereafter.  The closing price of the Issuer's common stock on the date of grant was $0.50."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the derivative securities shall vest fully on the first anniversary of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying the derivative securities shall vest fully on the first anniversary of grant."}],"balance_after":150000,"derivative":{"exercise_date":"2022-07-21","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-21-094965","document":"tm2123025d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000110465921094965/tm2123025d3_4.xml","form_type":"4"}},{"id":2900436,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-21T15:56:34.000Z","date":"2021-01-19","kind":"grant","acquired":true,"shares":106700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on January 19, 2022, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":106700,"derivative":{"exercise_price":19.61,"expiration_date":"2031-01-19","underlying":"Common Stock","underlying_shares":106700},"source":{"system":"sec-edgar","filing":"0001192482-21-000075","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119248221000075/edgar.xml","form_type":"4"}},{"id":2917757,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-01-06T11:09:20.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's equity compensation to its non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities vest fully 12 months from the date of grant."}],"balance_after":2000,"derivative":{"exercise_price":0.74,"exercise_date":"2022-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0000352998-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000035299821000004/primary_doc.xml","form_type":"4"}},{"id":3019682,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2020-09-30T17:50:07.000Z","date":"2020-09-29","kind":"grant","acquired":true,"shares":411400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option was granted on July 16, 2020 subject to stockholder approval, which was obtained at the Company's special meeting of stockholders on September 29, 2020. The Option vests 25% on July 16, 2021, with the remaining 75% vesting in equal monthly installments over 36 months, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date."}],"balance_after":411400,"derivative":{"exercise_price":11.9,"expiration_date":"2030-07-16","underlying":"Common Stock","underlying_shares":411400},"source":{"system":"sec-edgar","filing":"0001192482-20-000736","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119248220000736/edgar.xml","form_type":"4"}},{"id":3096382,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-06-30T21:00:22.000Z","date":"2020-06-26","kind":"other","acquired":true,"shares":25083,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Chondrial Therapeutics Holdings, LLC (\"Holdings\") to its members, for no consideration. The reporting person is a member of the board of managers and President and Chief Executive Officer of Holdings."}],"balance_after":25083,"source":{"system":"sec-edgar","filing":"0001192482-20-000586","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000119248220000586/edgar.xml","form_type":"4"}},{"id":3325429,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-01-03T10:54:19.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's equity compensation to its non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities shall vest fully 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":0.415,"exercise_date":"2021-01-02","expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-000634","document":"tm201128d3_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000110465920000634/tm201128d3_4.xml","form_type":"4"}},{"id":3397649,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-10-04T17:54:23.000Z","date":"2019-10-02","kind":"grant","acquired":true,"shares":10653,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued pursuant to the terms of the Non-employee Directors Compensation Policy as compensation for services provided to the Board for the fourth quarter of 2019."}],"balance_after":10653,"derivative":{"exercise_price":0.88,"exercise_date":"2020-10-02","expiration_date":"2029-10-02","underlying":"Common Stock","underlying_shares":10653},"source":{"system":"sec-edgar","filing":"0001144204-19-047417","document":"tv530697_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419047417/tv530697_form4.xml","form_type":"4"}},{"id":3469793,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-07-03T11:49:11.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":15385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued pursuant to the terms of the Non-employee Directors Compensation Policy as compensation for services provided to the Board for the third quarter of 2019."}],"balance_after":15385,"derivative":{"exercise_price":0.65,"exercise_date":"2020-07-01","expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":15385},"source":{"system":"sec-edgar","filing":"0001144204-19-033725","document":"tv524759_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419033725/tv524759_form4.xml","form_type":"4"}},{"id":3506844,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-31T10:39:33.000Z","date":"2019-05-30","kind":"purchase","acquired":true,"shares":10000,"price":0.5885,"value":5885.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.5759 to $0.5898, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001144204-19-029061","document":"tv522782_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419029061/tv522782_form4.xml","form_type":"4"}},{"id":3526960,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-05-15T18:24:51.000Z","date":"2019-05-13","kind":"grant","acquired":true,"shares":11628,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These securities were issued pursuant to the terms of the Non-employee Director Compensation Policy as compensation for services provided to the Board in the second quarter of 2019."}],"balance_after":11628,"derivative":{"exercise_price":0.86,"exercise_date":"2020-05-13","expiration_date":"2029-05-13","underlying":"Common Stock","underlying_shares":11628},"source":{"system":"sec-edgar","filing":"0001144204-19-026693","document":"tv521755_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419026693/tv521755_form4.xml","form_type":"4"}},{"id":3526959,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-05-15T18:24:51.000Z","date":"2019-05-13","kind":"grant","acquired":true,"shares":10901,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These securities were issued pursuant to the terms of the Non-employee Director Compensation Policy as compensation for services provided to the Board in the first quarter of 2019."}],"balance_after":10901,"derivative":{"exercise_price":0.86,"exercise_date":"2020-05-13","expiration_date":"2029-05-13","underlying":"Common Stock","underlying_shares":10901},"source":{"system":"sec-edgar","filing":"0001144204-19-026693","document":"tv521755_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419026693/tv521755_form4.xml","form_type":"4"}},{"id":3706401,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2019-01-04T16:01:08.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's equity compensation to its non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities shall vest fully 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":1.32,"exercise_date":"2020-01-02","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-19-000648","document":"tv510281_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420419000648/tv510281_4.xml","form_type":"4"}},{"id":4109440,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-01-04T16:19:06.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's equity compensation to its non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities shall vest fully 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":3.85,"exercise_date":"2019-01-02","expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-18-000824","document":"tv482606_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420418000824/tv482606_form4.xml","form_type":"4"}},{"id":4166762,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-13T17:01:54.000Z","date":"2017-11-13","kind":"purchase","acquired":true,"shares":3600,"price":3.483,"value":12538.8,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001144204-17-058444","document":"tv479369_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420417058444/tv479369_form4.xml","form_type":"4"}},{"id":4166761,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-13T17:01:54.000Z","date":"2017-11-13","kind":"purchase","acquired":true,"shares":1400,"price":3.4784,"value":4869.76,"ownership":{"direct":true},"balance_after":2400,"source":{"system":"sec-edgar","filing":"0001144204-17-058444","document":"tv479369_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420417058444/tv479369_form4.xml","form_type":"4"}},{"id":4500455,"issuer":{"id":134764,"kind":"organization","name":"Teligent, Inc.","symbol":"TLGT"},"owners":[{"id":68690,"kind":"person","name":"BEN-MAIMON CAROLE","position":1,"cik":"0001529611","reported_name":"BEN-MAIMON CAROLE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-01-05T16:12:34.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These securities were granted as part of the Issuer's equity compensation to its non-employee directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These securities shall vest fully 12 months from the date of grant."}],"balance_after":20000,"derivative":{"exercise_price":7.05,"exercise_date":"2018-01-03","expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001144204-17-000867","document":"v456323_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/352998/000114420417000867/v456323_form4.xml","form_type":"4"}}]}